AMYLIN PHARMACEUTICALS INC Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31)
AMYLIN PHARMACEUTICALS INC reported Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) of $273.84 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsFutureAmortizationExpense · last filed 2012-02-22
- AMYLIN PHARMACEUTICALS INC finite-lived intangible assets, future amortization expense (deprecated 2012-01-31) for fiscal 2011 was $273.84M.
| Period end | Finite-Lived Intangible Assets, Future Amortization Expense (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $273.84M 10-K · filed 2012-02-22 |